Assignee
MOGAM INST BIOMEDICAL RES
KR·12 granted patents·9 pending applications·17 citations·filing 2015–2022
Top patents by PatentIndex Score
21 records- 0188US10752697B2Anti-glypican 3 antibody and pharmaceutical composition containing the sameMOGAM INST BIOMEDICAL RES·Filed 2016·Granted Aug 25, 2020·6 cites·17 claims
- 0286US10851175B2Anti-mesothelin antibody and composition comprising the sameMOGAM INST BIOMEDICAL RES·Filed 2016·Granted Dec 1, 2020·5 cites·15 claims
- 0382US11447559B2Anti-BCMA antibody having high affinity for BCMA and pharmaceutical composition for treatment of cancer, comprising sameMOGAM INST BIOMEDICAL RES·Filed 2018·Granted Sep 20, 2022·2 cites·27 claims
- 0473US10940198B2Herpes zoster vaccine compositionMOGAM INST BIOMEDICAL RES·Filed 2017·Granted Mar 9, 2021·1 cites·8 claims
- 0573US10874734B2Varicella zoster virus vaccineMOGAM INST BIOMEDICAL RES·Filed 2017·Granted Dec 29, 2020·1 cites·6 claims
- 0671US11332528B2Anti-CEACAM1 antibody and use thereofMOGAM INST BIOMEDICAL RES·Filed 2018·Granted May 17, 2022·1 cites·32 claims
- 0761US10266607B2Antibody binding to TFPI and composition comprising the sameMOGAM INST BIOMEDICAL RES·Filed 2015·Granted Apr 23, 2019·1 cites·6 claims
- 0854US2023210985A1Varicella zoster virus vaccineMOGAM INST BIOMEDICAL RES·Filed 2022·Application pending·0 cites
- 0952US2021077616A1Varicella zoster virus vaccineMOGAM INST BIOMEDICAL RES·Filed 2020·Application pending·0 cites
- 1048US11642408B2Antigen variant of Varicella Zoster virus and use thereofMOGAM INST BIOMEDICAL RES·Filed 2019·Granted May 9, 2023·0 cites·12 claims
- 1145US12098209B2Fusion protein comprising IDS and use thereofMOGAM INST BIOMEDICAL RES·Filed 2019·Granted Sep 24, 2024·0 cites·16 claims
- 1245US2024182547A1Anti-rsv antibody and pharmaceutical composition comprising sameMOGAM INST BIOMEDICAL RES·Filed 2021·Application pending·0 cites
- 1344US11512126B2AB6 family designer ligands of TGF-β superfamilyMOGAM INST BIOMEDICAL RES·Filed 2017·Granted Nov 29, 2022·0 cites·2 claims
- 1444US2018168134A1Transgenic mouse expressing inactivated human iduronate-2-sulphatase and method for improving a hunter syndrome treating agent using sameMOGAM INST BIOMEDICAL RES·Filed 2017·Application pending·0 cites
- 1544US2020407713A1Transformed human cell and use thereofMOGAM INST BIOMEDICAL RES·Filed 2018·Application pending·0 cites
- 1642US12071710B2Antibody library and antibody screening method using sameMOGAM INST BIOMEDICAL RES·Filed 2019·Granted Aug 27, 2024·0 cites·10 claims
- 1739US2021079062A1In-vivo release sustained recombinant coagulation factor viii and preparation method thereforMOGAM INST BIOMEDICAL RES·Filed 2019·Application pending·0 cites
- 1837US11046749B2Chimera protein comprising FVIII and vWF factors, and use thereofMOGAM INST BIOMEDICAL RES·Filed 2017·Granted Jun 29, 2021·0 cites·15 claims
- 1937US2019135885A1Composition comprising an ab6 family designer ligand of tgf-beta superfamily for treating liver disease and use thereofMOGAM INST BIOMEDICAL RES·Filed 2017·Application pending·0 cites
- 2033US2019135884A1Composition comprising an ab6 family designer ligand of tgf-beta superfamily for treating bone and cartilage disease and use thereofMOGAM INST BIOMEDICAL RES·Filed 2017·Application pending·0 cites
- 2127US2019194618A1Method for measuring immunogenicity of protein agentMOGAM INST BIOMEDICAL RES·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MOGAM INST BIOMEDICAL RES files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →